Related references
Note: Only part of the references are listed.Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
Z. Y. Lim et al.
BONE MARROW TRANSPLANTATION (2010)
A modified comorbidity index for hematopoietic cell transplantation
T. E. DeFor et al.
BONE MARROW TRANSPLANTATION (2010)
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
Brian L. McClune et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
ZiYi Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center
R. Guilfoyle et al.
BONE MARROW TRANSPLANTATION (2009)
Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia
Olle Ringden et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants
Navneet S. Majbail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Acute myeloid leukemia in the elderly: Conventional and novel treatment approaches
Chad M. Craig et al.
BLOOD REVIEWS (2008)
Impact of comorbidity indexes on non-relapse mortality
A. Xhaard et al.
LEUKEMIA (2008)
Acute myeloid leukemia in the elderly
Herve Dombret et al.
SEMINARS IN ONCOLOGY (2008)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia
A-L Herr et al.
LEUKEMIA (2007)
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using campath-1H as part of a graft-versus-host disease strategy
Tsiporah Shore et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using BLA-identical sibling donors in myelodysplastic syndromes
Rodrigo Martino et al.
BLOOD (2006)
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia:: results from Cancer and Leukemia Group B 8461
Sherif S. Farag et al.
BLOOD (2006)
Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML
Dietger Niederwieser et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2006)
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia
S Tauro et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
M Aoudjhane et al.
LEUKEMIA (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
R Diaconescu et al.
BLOOD (2004)
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
R Chakraverty et al.
BLOOD (2002)
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial
AH Goldstone et al.
BLOOD (2001)
Share Paper
